Unlock instant, AI-driven research and patent intelligence for your innovation.

A method for preparing human-like sugar chains from Haemophilus influenzae based on the skeleton protein fn3

A technology of Haemophilus influenzae and skeleton protein, applied in the biological field, can solve the problems of loss of activity and difficulty in preparing humanized oligosaccharides, and achieve the effects of efficient preparation, improvement of physical and chemical properties, and improvement of pharmacokinetic properties

Active Publication Date: 2019-11-29
大连金荣班德生物技术有限公司
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, because some eukaryotic oligosaccharide transferases lose their activity after being expressed in Escherichia coli, further research and preparation of humanized oligosaccharides face great difficulties

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A method for preparing human-like sugar chains from Haemophilus influenzae based on the skeleton protein fn3
  • A method for preparing human-like sugar chains from Haemophilus influenzae based on the skeleton protein fn3
  • A method for preparing human-like sugar chains from Haemophilus influenzae based on the skeleton protein fn3

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] 1. In this example, human fibronectin type III domain (Fn3) protein is used as a model gene (EMBL accession number AJ320527). According to the modeling results, the glycosylation modification site was designed at the C-terminal of the Fn3 backbone protein, the amino acid sequence of the glycosylation site DQNAT was selected, and a separation and purification tag (His-tag) encoding 6 histidines was fused downstream of the gene. ), easy to separate and purify, named as Fn3-Gly, fusion gene structure see figure 1 .

[0035] The fusion gene shown in the sequence list [002] is synthesized (Nanjing KingScript Biotechnology Co., Ltd.), constructed on the Escherichia coli periplasmic cavity expression vector pIG6 with Nco I and Hind III, and obtains the recombinant vector pIG6-Fn3-Gly, fusion gene structure see figure 2 .

[0036] 2. Integrate the prokaryotic oligosaccharide synthesis mechanism and rebuild the glycosylation pathway in E. coli. The specific steps are as fol...

Embodiment 2

[0044] 1. In this example, human fibronectin type III domain (Fn3) protein is used as a model gene (EMBL accession number AJ320527). According to the modeling results, the glycosylation modification site was designed at the C-terminus of the Fn3 backbone protein, the amino acid sequence of the glycosylation site DQNAT was selected, and a separation and purification tag encoding 6 histidines (His-tag ), easy to separate and purify, named as Fn3-Gly, fusion gene structure see figure 1 .

[0045] The fusion gene synthesis (Nanjing KingScript Biotechnology Co., Ltd.) shown in the sequence table [002] was constructed on the E. coli periplasmic cavity expression vector pIG6 with Nco I and Hind III to obtain the recombinant vector pIG6-Fn3-Gly, fusion gene structure see figure 2 .

[0046] 2. Integrate the prokaryotic oligosaccharide synthesis mechanism and rebuild the glycosylation pathway in E. coli. The specific steps are as follows: (1) The oligosaccharidyl transferase gene ...

Embodiment 3

[0054] 1. In this example, human fibronectin type III domain (Fn3) protein is used as a model gene (EMBL accession number AJ320527). According to the modeling results, the glycosylation modification site was designed at the C-terminus of the Fn3 backbone protein, the amino acid sequence of the glycosylation site DQNAT was selected, and a separation and purification tag encoding 6 histidines (His-tag ), easy to separate and purify, named as Fn3-Gly, fusion gene structure see figure 1 .

[0055] The fusion gene synthesis (Nanjing KingScript Biotechnology Co., Ltd.) shown in the sequence table [002] was constructed on the E. coli periplasmic cavity expression vector pIG6 with Nco I and Hind III to obtain the recombinant vector pIG6-Fn3-Gly, fusion gene structure see figure 2 .

[0056] 2. Integrate the prokaryotic oligosaccharide synthesis mechanism and rebuild the glycosylation pathway in E. coli. The specific steps are as follows: (1) The oligosaccharidyl transferase gene ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of biotechnology and relates to a method for preparing haemophilus influenza Gal beta 1-4GlcNAc beta 1-3Gal beta 1-3GlcNAc quasi-human-derived carbohydrate chain based on human skelemin Fn3. The method comprises the steps of establishing a recombinant vector suitable for expression of escherichia coli K-12 series strain by comprehensively utilizing a haemophilus influenza lsg gene cluster lipopolysaccharide synthesis mechanism, a campylobacter jejuni pgl gene cluster N-carbohydrate chain synthesis mechanism, an escherichia coli in-vivo O antigen carbohydrate chain synthesis mechanism and a prokaryote transcriptional control mechanism; displaying the quasi-human-derived carbohydrate chain in escherichia coli by means of human-derived skelemin Fn3. The method has the advantages that fusion protein with the quasi-human-derived carbohydrate chain can be prepared easily, quickly and efficiently, and a foundation is provided for efficient low-cost large-scale preparation of quasi-human-derived oligosaccharide and N-glycosylation carbohydrate chain modified drug protein.

Description

technical field [0001] The invention belongs to the field of biotechnology, and relates to a method for preparing Haemophilus influenzae Galβ1-4GlcNAcβ1-3Galβ1-3GlcNAc-like human sugar chains based on human skeleton protein Fn3. The present invention can simply, rapidly and efficiently prepare the fusion protein displaying Haemophilus influenzae-like human-derived sugar chains Galβ1-4GlcNAcβ1-3Galβ1-3GlcNAc-, that is, the glycoprotein complex with human-derived sugar chain terminal Galβ1-4GlcNAc, which can be further It is applied to the research and development and mass production of various human-like sugar chains in Escherichia coli. Background technique [0002] After nearly two decades of development in glycobiology, people have now deeply realized the important functions of sugar chains: sugar chains can not only affect the folding, polymerization, dissolution and degradation of glycoprotein peptide chains, but also participate in the sorting of glycoproteins. ) and c...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/70C12N15/62C07K19/00
CPCC07K14/78C07K2319/21C12N15/62C12N15/70
Inventor 丁宁胡学军杨春光孙慎侠杨岩韩立赤张嘉宁
Owner 大连金荣班德生物技术有限公司